development—the pandemic has also drawn attention to innovation policy failures. Policymakers should focus on addressing these …The COVID-19 crisis has starkly illustrated both the strengths and limitations of U.S. biomedical innovation … institutions as deployed to fight a pandemic. These innovation institutions include not just intellectual property law, but also …

large and complex market. Our study generates several interesting results related to the adoption and diffusion of Health … types of urban and rural counties, on the likelihood of adoption; (5) market competitive forces appear to have a mixed … of healthcare, and crafting appropriate policy responses. We note some future extensions of our work. -- healthcare …

) vendors. By adopting a system popular in the local market, hospitals may benefit from complementarities but also worry about … tradeoff between scale economies from system uniformity and external local market complementarities, when the choice of the … chain differs from that in the market. I develop and estimate a discrete-choice model to study these dynamics in the …

This paper - written for an edited volume addressing how law and policy can keep pace with highly dynamic scientific … and technological innovation - proposes an international framework to coordinate and facilitate national responses to … international framework convention on innovation and regulation, which could be supplemented by specific protocols in particular …

, along with a more complex set of innovation incentives. This chapter presents background on medical device regulation … adverse events and recalls), and concludes with a discussion of the implications of regulation for innovation incentives in …

hospitals' digital integration and operational efficiency. It remains uncertain whether current policy efforts to increase …

-in-part) that human gene patents "present a significant obstacle to the next generation of innovation in genetic medicine … single "Policy Perspective" article published in Science in 2005, and an unfortunate tendency among many commentators to … over gene patents. Ironically, it might be the case that the next generation of genetic diagnostic testing innovation will …

specific patent doctrines that can provide or help provide sufficient incentives for health-related innovation? Second, is …

cell products both before and after market entry. The article first scrutinizes some suggested regulatory solutions and … cell products on the market in the United States, this current paucity is likely temporary. Vigorous FDA oversight will be … necessary once applications to approve these products and place them on the market arrive in large numbers. Because stem cell …